NEW YORK and HAIKOU, China, Aug. 1 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. (''China Pharma'') (OTC Bulletin Board: CPHI) which develops, manufactures, and markets leading off-patent brand and newly developed products in China, today announced the Company will host an earning conference call at 10:00 a.m. EDT on Wednesday, August 6, 2008 to discuss these results. The Company also plans to release its earnings earlier that same day.
Ms. Zhilin Li, President and CEO of China Pharma Holdings, Inc., Mr. Xinhua Wu, Chief Financial Officer, and Mr. Alan Sheinwald, Partner of HC International will be hosting the call. To participate in the conference call, please dial 1-800-591-6945 ten minutes prior to the scheduled conference call time. International callers should dial 1-617-614-4911. The conference pass code is 11374834.
If you are unable to participate in the call at this time, a replay will be available on Wednesday, August 6 at 12:00 p.m. EDT, through Wednesday, August 13. To access the replay, please dial 1-888-286-8010. International callers should dial 1-617-801-6888. The conference pass code is 77875355. This conference call will be broadcast live over the Internet and can be accessed by clicking this link: http://phx.corporate-ir.net/playerlink.zhtml?c=145098&s=wm&e=1914439 . A replay will also be available shortly after the call on China Pharma' website http://www.chinapharmaholdings.com .
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. develops, manufactures, and markets leading
off-patend brand and newly developed products in China that treat a wide
range of conditions, including infections, hepatitis, cardiovascular,
cerebrovascular, CNS, and other prevailing diseases. Helpson
Bio-pharmaceutical Co., Ltd (Helpson), a specialty pharm
|SOURCE China Pharma Holdings, Inc.|
Copyright©2008 PR Newswire.
All rights reserved